Here's a listing of recent physician appointments around the United States.
Edward M. Barksdale, Jr., MD has been named chief of pediatric general surgery and the first holder of the Robert J. Izant, Jr., MD chair in pediatric surgery at University Hospitals' Case Medical Center's Rainbow Babies & Children's Hospital in Cleveland.
David G. Jaimovich, MD of Highland Park, Ill. has been appointed chief medical officer at the Joint Commission on Accreditation of Healthcare Organizations, where he will oversee the international accreditation and domestic projects for quality, performance, and patient safety initiatives.
Jonathan D. Klein, MD, MPH of Rochester, N.Y., has been appointed associate chair for community and government affairs in the department of pediatrics at the University of Rochester School Medicine and Dentistry in Rochester.
Philip O. Ozuah, MD, PhD of Chestnut Ridge, N.Y., has been named chairman of pediatrics at Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, N.Y. He also was named physician-in-chief at The Children's Hospital at Montefiore.
Arnold W. Strauss, MD has been named chairman of pediatrics at University of Cincinnati and director of the Cincinnati Children's Research Foundation.
Griffin P. Rogers, MD has been appointed director of the National Institute of Diabetes and Digestive and Kidney Diseases, which is a part of the National Institutes of Health in Bethesda, Md. The Institute conducts and supports research on diabetes, endocrinology, and metabolic diseases; digestive diseases and nutrition; and kidney, urologic, and hemotologic diseases.
Barbara Alving, MD has been appointed director of the National Institute of Health's National Center for Research Resources, Bethesda, Md. The Center provides laboratory scientists and clinical researchers with the environments and tools they need to understand, detect, treat, and prevent a variety of diseases.
Study shows dengue vaccine is safe and effective
October 11th 2024Overall, 2 doses of TAK-003 successfully induced the production of neutralizing antibodies against all 4 dengue serotypes in at least 90% of adults, children, and adolescents, regardless of whether they were seronegative or seropositive at baseline.